ES2179093T3 - Inhibidores de la prolilendopeptidasa. - Google Patents
Inhibidores de la prolilendopeptidasa.Info
- Publication number
- ES2179093T3 ES2179093T3 ES95901820T ES95901820T ES2179093T3 ES 2179093 T3 ES2179093 T3 ES 2179093T3 ES 95901820 T ES95901820 T ES 95901820T ES 95901820 T ES95901820 T ES 95901820T ES 2179093 T3 ES2179093 T3 ES 2179093T3
- Authority
- ES
- Spain
- Prior art keywords
- inhibitors
- compounds
- formula
- present
- prolilendopeptidasa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE FORMULA (I), QUE COMPRENDE TODOS SUS ESTEREOISOMEROS, COMPOSICIONES Y PROCESOS PARA SU PREPARACION. LOS COMPUESTOS DE LA PRESENTE INVENCION TAMBIEN SON UTILES EN SUS ACTIVIDADES FARMACOLOGICAS YA QUE ACTUAN DIRECTAMENTE COMO INHIBIDORES DE PROPIL ENDOPEPTIDASA Y COMO TAL PREVEN UN METODO PARA MEJORAR LA MEMORIA, PREVENIR O REDUCIR LOS EFECTOS DE LA AMNESIA O LOS DEFICITS DE MEMORIA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16110693A | 1993-12-02 | 1993-12-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2179093T3 true ES2179093T3 (es) | 2003-01-16 |
Family
ID=22579844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95901820T Expired - Lifetime ES2179093T3 (es) | 1993-12-02 | 1994-11-08 | Inhibidores de la prolilendopeptidasa. |
Country Status (19)
Country | Link |
---|---|
US (1) | US5661167A (es) |
EP (1) | EP0731788B1 (es) |
JP (1) | JPH09506090A (es) |
KR (1) | KR100341982B1 (es) |
CN (1) | CN1136806A (es) |
AT (1) | ATE223894T1 (es) |
AU (1) | AU684861B2 (es) |
CA (1) | CA2177821C (es) |
DE (1) | DE69431359T2 (es) |
DK (1) | DK0731788T3 (es) |
ES (1) | ES2179093T3 (es) |
HU (1) | HUT74687A (es) |
IL (1) | IL111775A (es) |
NO (1) | NO962238D0 (es) |
NZ (1) | NZ276600A (es) |
PT (1) | PT731788E (es) |
TW (1) | TW280818B (es) |
WO (1) | WO1995015310A1 (es) |
ZA (1) | ZA949302B (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5859031A (en) | 1995-06-07 | 1999-01-12 | Gpi Nil Holdings, Inc. | Small molecule inhibitors of rotamase enzyme activity |
ZA200508439B (en) | 2003-05-05 | 2007-03-28 | Probiodrug Ag | Medical use of inhibitors of glutaminyl and glutamate cyclases |
EP1824846A2 (en) | 2003-11-03 | 2007-08-29 | Probiodrug AG | Novel compounds for the treatment of neurological disorders |
ZA200603165B (en) | 2003-11-03 | 2007-07-25 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
EP1713780B1 (en) | 2004-02-05 | 2012-01-18 | Probiodrug AG | Novel inhibitors of glutaminyl cyclase |
WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
US9126987B2 (en) | 2006-11-30 | 2015-09-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
CN101668525A (zh) | 2007-03-01 | 2010-03-10 | 前体生物药物股份公司 | 谷氨酰胺酰环化酶抑制剂的新用途 |
EP2142514B1 (en) | 2007-04-18 | 2014-12-24 | Probiodrug AG | Thiourea derivatives as glutaminyl cyclase inhibitors |
US8524654B2 (en) * | 2007-05-21 | 2013-09-03 | The Uab Research Foundation | Prolyl endopeptidase inhibitors for reducing or preventing neutrophilic inflammation |
SG178953A1 (en) | 2009-09-11 | 2012-04-27 | Probiodrug Ag | Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
ES2586231T3 (es) | 2010-03-03 | 2016-10-13 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
DK2545047T3 (da) | 2010-03-10 | 2014-07-28 | Probiodrug Ag | Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5) |
WO2011131748A2 (en) | 2010-04-21 | 2011-10-27 | Probiodrug Ag | Novel inhibitors |
ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
US9771786B2 (en) | 2014-01-28 | 2017-09-26 | Spirit Global Energy Solutions, Inc. | Down-hole gas and solids separator utilized in production hydrocarbons |
PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4518528A (en) * | 1983-05-19 | 1985-05-21 | Rasnick David W | α Amino fluoro ketones |
CA1341029C (en) * | 1985-02-04 | 2000-06-20 | Michael Kolb | Peptidase inhibitors |
DE3712365A1 (de) * | 1987-04-11 | 1988-10-27 | Hoechst Ag | Neue 2-acylpyrrolidin-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel sowie deren verwendung |
US4855303A (en) * | 1987-07-01 | 1989-08-08 | Pfizer Inc. | Fluorine containing renin inhibitors |
JPH0662591B2 (ja) * | 1988-12-14 | 1994-08-17 | 株式会社ヤクルト本社 | 新規なチオプロリン誘導体 |
US5118811A (en) * | 1989-04-13 | 1992-06-02 | Japan Tobacco Inc. | Amino acid derivatives possessing prolyl endopeptidase-inhibitory activities |
-
1994
- 1994-11-08 DK DK95901820T patent/DK0731788T3/da active
- 1994-11-08 HU HU9601472A patent/HUT74687A/hu unknown
- 1994-11-08 NZ NZ276600A patent/NZ276600A/en unknown
- 1994-11-08 KR KR1019960702894A patent/KR100341982B1/ko not_active IP Right Cessation
- 1994-11-08 CN CN94194374A patent/CN1136806A/zh active Pending
- 1994-11-08 WO PCT/US1994/012865 patent/WO1995015310A1/en active IP Right Grant
- 1994-11-08 DE DE69431359T patent/DE69431359T2/de not_active Expired - Fee Related
- 1994-11-08 JP JP7515618A patent/JPH09506090A/ja not_active Ceased
- 1994-11-08 AU AU10917/95A patent/AU684861B2/en not_active Ceased
- 1994-11-08 AT AT95901820T patent/ATE223894T1/de not_active IP Right Cessation
- 1994-11-08 ES ES95901820T patent/ES2179093T3/es not_active Expired - Lifetime
- 1994-11-08 CA CA002177821A patent/CA2177821C/en not_active Expired - Fee Related
- 1994-11-08 EP EP95901820A patent/EP0731788B1/en not_active Expired - Lifetime
- 1994-11-08 PT PT95901820T patent/PT731788E/pt unknown
- 1994-11-23 ZA ZA949302A patent/ZA949302B/xx unknown
- 1994-11-24 TW TW083110932A patent/TW280818B/zh active
- 1994-11-27 IL IL111775A patent/IL111775A/en not_active IP Right Cessation
-
1996
- 1996-05-31 NO NO962238A patent/NO962238D0/no not_active Application Discontinuation
- 1996-12-02 US US08/759,323 patent/US5661167A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IL111775A0 (en) | 1995-01-24 |
DK0731788T3 (da) | 2003-01-20 |
KR100341982B1 (ko) | 2002-11-30 |
PT731788E (pt) | 2003-01-31 |
HUT74687A (en) | 1997-01-28 |
IL111775A (en) | 1998-06-15 |
AU1091795A (en) | 1995-06-19 |
DE69431359D1 (de) | 2002-10-17 |
NZ276600A (en) | 1997-09-22 |
JPH09506090A (ja) | 1997-06-17 |
ZA949302B (en) | 1995-08-07 |
US5661167A (en) | 1997-08-26 |
ATE223894T1 (de) | 2002-09-15 |
TW280818B (es) | 1996-07-11 |
CA2177821C (en) | 2000-03-28 |
CA2177821A1 (en) | 1995-06-08 |
HU9601472D0 (en) | 1996-07-29 |
WO1995015310A1 (en) | 1995-06-08 |
NO962238L (no) | 1996-05-31 |
EP0731788A1 (en) | 1996-09-18 |
EP0731788B1 (en) | 2002-09-11 |
NO962238D0 (no) | 1996-05-31 |
AU684861B2 (en) | 1998-01-08 |
CN1136806A (zh) | 1996-11-27 |
DE69431359T2 (de) | 2003-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2179093T3 (es) | Inhibidores de la prolilendopeptidasa. | |
BG103485A (en) | Ketobanzamides as calpain inhibitors | |
ES2092113T3 (es) | Derivados fluoroalcoxibencilamino de heterociclos que contienen nitrogeno. | |
TR199802767T2 (xx) | Trombin �nleyiciler olarak yeni amidino t�revleri. | |
BR9408246A (pt) | Composto derivado de 3-azabicicloalcano N-substituído | |
ATE148130T1 (de) | Typ-iv-dipeptidyl-aminopeptidase-inhibitoren | |
CA2244785A1 (en) | Pentafluorobenzenesulfonamides and analogs | |
TR199700844T1 (xx) | Pirazolil-Benzoil T�revleri. | |
DE69705300T2 (de) | Cyclopropylalkansäurederivate | |
ES2132415T3 (es) | Nuevos derivados de 5-pirrolil-2-piridilmetilsulfinilbencimidazol. | |
DK0830350T3 (da) | Hidtil ukendte N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[B][1,5]diazepin-3-yl)acetamider | |
DE69516128T2 (de) | Mercaptoacetylamid-1,3,4,5-tetrahydrobenzo(c)azepin-3-ein disulfidderivate als enkephalinase und ace inhibitoren | |
EA200200510A1 (ru) | 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр | |
TR199801935T2 (xx) | N�trofil elastaz inhibit�rleri olarak pirolopirolon t�revleri. | |
CA2266759A1 (en) | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase | |
CA2356985A1 (en) | 5ht1 antagonists for antidepressant therapy | |
MY120550A (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions. | |
FI962323A0 (fi) | N-substituoidut atsabisykloheptaanijohdannaiset, kuten esim. neuroleptit | |
PT96849A (pt) | Processo de preparacao de novos derivados da beta-fenil-iso-serina e de beta-fenil-iso-serina-(2r,2s) | |
TR199901416T2 (xx) | Heterosiklik karbonikasit t�revleri. | |
TR199800210T2 (xx) | Didepsipeptid temelli endoparazitisid kompozisyonlar, yeni didepsipeptidler ve bunlar�n �retimi i�in i�lemler. | |
ES2128031T3 (es) | Forma cristalina y polimorfica de (s,s,s)-n-(1-(2-carboxi-3-(n2-mesilisilamino)propil)-1-ciclopentilcarbonil)tirosina. | |
PL322969A1 (en) | Substituted phenylamidines, pharmaceutic compositions containing theses compounds and method of obtaining them | |
BR9407232A (pt) | Compostos de tiocarbamoíla | |
KR960700223A (ko) | C-치환 디에틸렌 트리아민의 제조 방법(Process for the Production of C-Substituted Diethylenetriamines) |